跳至主要内容
临床试验/JPRN-jRCT1030200276
JPRN-jRCT1030200276进行中(未招募)未知

Efficacy of self-sampling for human papilloma virus test in cervical cancer screening uptake and precancer detection: a randomized control trial - ACCESS trial

Hata Akira0 个研究点目标入组 20,000 人开始时间: 2020年12月25日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
20,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 30age old 至 < 60age old(—)
性别
Female

入选标准

  • 1. Female residents of Ichihara City at the time of extraction
  • 2. Target residents for cervical cancer screening in the fiscal year 2021 (even-numbered age)
  • 3. Residents aged 30 years to 59 years at the point of April 1 in 2021
  • 4. Residents who have not participated in the screening by Ichihara City for more than three years

排除标准

  • 1. Residents with unknown address

研究者

发起方
Hata Akira

相似试验

Accelerating Cervical Cancer Elimination by... | 临床试验